Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Baicalein in Translational Oncology: Bridging Mechanism with
2026-05-30
This thought-leadership article explores Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) as a high-impact research tool for translational scientists targeting apoptosis, inflammation, and cancer pathways. We dissect the mechanistic basis of its 12-LOX inhibition, contrast its utility across preclinical models, and offer strategic guidance for workflow design—integrating comparisons to emerging neuroprotective paradigms such as the Nrf2/HO-1 axis. Protocol parameters, competitive context, and future outlooks are tailored for bench-to-bedside relevance, with direct links to authoritative product and protocol resources. This article goes beyond standard product pages by offering actionable insights, evidence synthesis, and a vision for next-generation research.
-
Pharmacokinetics of CSBTA in MASH: Variability and Implicati
2026-05-29
This article examines the recent investigation into the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mouse models of metabolic dysfunction-associated steatohepatitis (MASH). The study reveals how disease state and dosing frequency significantly alter systemic exposure and hepatic accumulation of CSBTA alkaloids, providing critical guidance for rational MASLD/MASH therapy design.
-
Plerixafor (AMD3100): Reliable CXCR4 Inhibition in Lab Assay
2026-05-29
This article delivers practical, evidence-based guidance for life science researchers leveraging Plerixafor (AMD3100) (SKU A2025) in cell viability, proliferation, and immune modulation workflows. By addressing common experimental challenges and benchmarking against emerging alternatives, it demonstrates the proven reliability and reproducibility of APExBIO’s Plerixafor (AMD3100) for cancer biology and stem cell mobilization assays.
-
Phosphatase Inhibitor Cocktail 3: Enhancing Phosphoprotein A
2026-05-28
Phosphatase Inhibitor Cocktail 3 (100X in DMSO) streamlines the preservation of protein phosphorylation, enabling reliable phosphoprotein analysis across Western blotting, kinase assays, and co-IP workflows. This APExBIO solution uniquely targets key serine/threonine phosphatases, ensuring signal fidelity even in challenging cellular signaling studies.
-
Actinomycin D in Cancer Research: Applied Workflows & Optimi
2026-05-28
Actinomycin D (ActD) is a gold-standard transcriptional inhibitor powering advanced cancer research and RNA stability assays. This article breaks down best-practice workflows, experimental troubleshooting, and actionable insights from breakthrough glioma studies, leveraging APExBIO’s high-purity formulation for reproducible, high-impact results.
-
HyperFluor 488 Goat Anti-Human IgG Antibody: Workflow Master
2026-05-27
The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody elevates immunofluorescence and immunoassay workflows with high sensitivity, specificity, and robust signal amplification. Its versatility streamlines advanced detection in Western blotting, flow cytometry, and multiplexed applications, supporting high-impact translational research.
-
Ether Lipid Biosynthesis in B Cells Regulates Antibody Respo
2026-05-27
This study uncovers how B cell-intrinsic expression of PexRAP, a key enzyme in ether lipid biosynthesis, directly influences antibody affinity maturation and germinal center development. The findings highlight a metabolic mechanism that shapes humoral immunity, with implications for immunology research and advanced mouse model design.
-
Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi
2026-05-26
Anlotinib hydrochloride is a potent multi-target tyrosine kinase inhibitor with nanomolar efficacy against VEGFR2, PDGFRβ, and FGFR1. It demonstrates strong anti-angiogenic activity and favorable pharmacokinetics for cancer research. APExBIO's C8688 formulation offers validated selectivity and workflow reproducibility.
-
Vardenafil HCl Trihydrate: Precision Tools for PDE5 Isoform
2026-05-26
Explore how Vardenafil HCl Trihydrate empowers researchers to dissect PDE5 isoform selectivity and proteoform-specific interactions, advancing cGMP signaling pathway studies. This article offers a unique, in-depth perspective on using Vardenafil in native proteomics and assay design.
-
SAR405: Decoding Vps34 Inhibition for Selective Autophagy Co
2026-05-25
Explore how SAR405, a potent Vps34 inhibitor, enables precise autophagy inhibition and vesicle trafficking studies. This article uniquely bridges mechanistic insights with practical assay design, integrating new paradigms from recent AMPK research.
-
Cy3 NHS ester (non-sulfonated): Technical Guide for Biomolec
2026-05-25
Cy3 NHS ester (non-sulfonated) enables precise fluorescent labeling of proteins, peptides, and oligonucleotides by targeting primary amines. It is best applied where robust, organic-solvent-compatible labeling is required and is not suitable for workflows that demand strict aqueous-only conditions or for labeling delicate proteins without a co-solvent.
-
Anti-Fibrotic Action of 1-Phenyl-2-Pentanol in Hepatic Stell
2026-05-24
This study identifies 1-phenyl-2-pentanol, isolated from Moringa oleifera, as a potent inhibitor of hepatic stellate cell activation through dual modulation of TGF-β1 and Wnt/β-catenin pathways. The findings provide mechanistic insight into anti-fibrotic therapy development and inform experimental modeling of liver fibrosis.
-
Structural Insights into Nipah Virus Polymerase Complex Asse
2026-05-23
The reference study delivers high-resolution structures of the Nipah virus L-P polymerase complex, uncovering the molecular organization and interactions essential for viral RNA synthesis. These findings provide a crucial foundation for structure-based antiviral development targeting henipavirus replication machinery.
-
SAR405: Redefining Vps34 Inhibition for Autophagy Research
2026-05-22
Explore how SAR405, a highly selective Vps34 inhibitor, enables unprecedented precision in dissecting autophagy and vesicle trafficking. This article delivers new scientific depth and protocol guidance, building on recent discoveries in AMPK-ULK1-Vps34 signaling.
-
Beyond Disulfide Reduction: Advanced Roles of TCEP Hydrochlo
2026-05-22
Explore how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is redefining protein modification and assay sensitivity, with a deep dive into its mechanistic impact on modern biochemical workflows. Learn why APExBIO’s TCEP hydrochloride is pivotal for advanced protein analysis and innovative capture-and-release strategies.